These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30117481)

  • 1. Proptosis and hemiplegia as an initial manifestation of multiple myeloma.
    Tahiliani N; Kataria P; Patel A; Kendre P
    J Postgrad Med; 2018; 64(4):243-246. PubMed ID: 30117481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen].
    Szturz P; Jakubcová R; Adam Z; Klincová M; Krejcí M; Pour L; Zahradová L; Hájek R; Mayer J
    Klin Onkol; 2011; 24(3):216-20. PubMed ID: 21717791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
    Grannis CH; Dewan VN; Wang RC
    Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extramedullary multiple myeloma with central nervous system and multiorgan involvement: Case report and literature review.
    Lee W; Chen RC; Swaminathan SK; Ho CL
    J Radiol Case Rep; 2019 Dec; 13(12):1-12. PubMed ID: 32184923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma presenting with hepatosplenomegaly.
    Mallavarapu KM; Rajappa S; Linga VG; Gundeti S; Digumarthi R; Uppin SG
    J Assoc Physicians India; 2011 Jul; 59():456-8. PubMed ID: 22315756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma invasion of the central nervous system.
    Marjanović S; Mijusković Z; Stamatović D; Madjaru L; Ralić T; Trimcev J; Stojanović J; Radović V
    Vojnosanit Pregl; 2012 Feb; 69(2):209-13. PubMed ID: 22500379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A; Siracusano L; Armando S
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma predominantly involving the spleen].
    Ryzhko VV; Klodzinskiĭ AA; Grachev AE; Varlamova EIu; Sataeva MS
    Ter Arkh; 2013; 85(7):84-6. PubMed ID: 24137953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system involvement in Multiple Myeloma-Diagnosis, treatment and outcome: A case report.
    Ali MU; Maqsood S; Malik M; Bano K
    J Pak Med Assoc; 2021 Nov; 71(11):2659-2661. PubMed ID: 34783755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marizomib for central nervous system-multiple myeloma.
    Badros A; Singh Z; Dhakal B; Kwok Y; MacLaren A; Richardson P; Trikha M; Hari P
    Br J Haematol; 2017 Apr; 177(2):221-225. PubMed ID: 28387460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case-control study of multiple myeloma patients with central nervous system involvement].
    Li L; Feng ZY; Guo P; He HY; Lu J; Liu J; Qiang WT; Jiang H; Du J; Fu WJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1016-1020. PubMed ID: 36709107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Salvage therapy with proteasome inhibitor bortezomib for relapsed and refractory multiple myeloma].
    Huang WR; Li R; Jing Y; Zhang YZ; Wu XX; Gao CJ; Bo J; Yu L; Wang QS; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1146-50. PubMed ID: 17204182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
    Méndez CE; Hwang BJ; Destian S; Mazumder A; Jagannath S; Vesole DH
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):220-3. PubMed ID: 20511169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Unusual Cause of Altered Mental Status in Multiple Myeloma: An Extraosseous Manifestation.
    Jaruvongvanich V; Spanuchart I; O-Charoen P; Kitamura C; Sumida L; Roytman M
    Hawaii J Med Public Health; 2016 Apr; 75(4):109-12. PubMed ID: 27099806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
    Adam Z; Feit J; Krejcí M; Pour L; Vasků V; Cermáková Z; Mayer J; Hájek R
    Vnitr Lek; 2009 Oct; 55(10):981-90. PubMed ID: 19947244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.
    Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H
    J Clin Exp Hematop; 2019 Sep; 59(3):135-139. PubMed ID: 31391406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgD myeloma manifesting as acute renal insufficiency].
    Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
    Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgD multiple myeloma with central nervous system involvement: A case report and literature review.
    Chen Y; Qiu Y; Fu H; Li J; Chen L; Liao S; Liu T
    Mol Clin Oncol; 2021 Oct; 15(4):198. PubMed ID: 34462654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.